VISCHER acted as Swiss counsel to Dermavant in the transaction. Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, entered...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here